| NCLEX | WCMNX | NCLEX / WCMNX | |
| Total Expense Ratio | 0.86 | 1.24 | 69% |
| Annual Report Gross Expense Ratio | 0.86 | 2.04 | 42% |
| Fund Existence | 39 years | 7 years | - |
| Gain YTD | -2.726 | 10.111 | -27% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 1000 | 10,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 333M | 52.2M | 638% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -14.90 | 16.84 | -88% |
| Returns for 3 years | -11.66 | 21.90 | -53% |
| Returns for 5 years | -31.57 | -2.29 | 1,377% |
| Returns for 10 years | -0.50 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSCZX | 59.94 | 0.39 | +0.65% |
| Columbia Small Cap Value Discv Inst | |||
| EXOSX | 37.92 | N/A | N/A |
| Manning & Napier Overseas Series I | |||
| IGIIX | 43.93 | N/A | N/A |
| Nomura Global Growth Fund Class I | |||
| JDEUX | 51.14 | N/A | N/A |
| JPMorgan US Research Enhanced Equity R6 | |||
| STRGX | 66.85 | N/A | N/A |
| Sterling Capital MdCp Relatv Val Instl | |||